Nutshell Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Buy
25,130
+19,230
+326% +$10.8M 4.41% 7
2026
Q1
$3.32M Buy
+5,900
New +$3.78M 1.8% 18
2025
Q3
Sell
-6,223
Closed -$3.34M 29
2025
Q2
$3.34M Sell
6,223
-3,884
-38% -$1.86M 1.99% 15
2025
Q1
$4.24M Sell
10,107
-325
-3% -$141K 2.21% 16
2024
Q4
$4.31M Buy
+10,432
New +$4.58M 2.73% 15

Other funds holding IDXX

Nutshell Asset Management's IDXX Position: Q2 2026 in Review

Nutshell Asset Management increased its Idexx Laboratories (IDXX) stake by 326% in Q2 2026, buying an estimated $10.8M and bringing the position to 25,130 shares worth $13.2M. The position accounts for 4.41% of the portfolio, ranked #7.

Nutshell Asset Management first reported a position in IDXX in Q4 2024 and has held it in 5 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Nutshell Asset Management held 25,130 shares of Idexx Laboratories worth $13.2M as of Q2 2026.
  • Nutshell Asset Management bought 19,230 Idexx Laboratories shares in Q2 2026, an estimated $10.8M.
  • Idexx Laboratories made up 4.41% of Nutshell Asset Management's portfolio in Q2 2026, its #7 holding.
  • Nutshell Asset Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 5 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Nutshell Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.